This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: FDA approves new generic valsartan, smartwatch detects atrial fibrillation
Click Here to Manage Email Alerts
Among the top cardiology stories last week were the FDA approval of a generic form of valsartan to address recalls of that same type of drug and results of an app-based study that showed a smartwatch helped clinicians diagnose atrial fibrillation.
Other popular stories included the launch of a new toolkit to help patients control BP, findings that suggested bempedoic acid combined with statin therapy reduced LDL and data that provided insight into how out-of-hospital cardiac arrest in adults was the third-highest rate of health loss due to fatal and nonfatal disease burden. – by Janel Miller
FDA approves new generic valsartan to address shortage
The FDA announced that it has approved a generic version of valsartan for the treatment of patients with high BP and heart failure. Read more.
Apple Heart Study forms ‘solid foundation’ for atrial fibrillation detection via smartwatch
NEW ORLEANS — Anticipated results of the Apple Heart Study, which evaluated how well a smartwatch can identify and prompt subsequent clinical evaluation, were presented before a packed room at the American College of Cardiology Scientific Session. Read more.
New American Heart Association toolkit designed to help control BP
The American Heart Association has created a resource center to help doctors, healthcare providers and patients treat and control high BP. Read more.
CLEAR Harmony: Bempedoic acid with statin therapy lowers LDL
Patients with either atherosclerotic CVD, heterozygous familial hypercholesterolemia or both who were assigned bempedoic acid with maximally tolerated statin therapy had significant decreases in LDL levels without a higher incidence of overall adverse events compared with those assigned placebo, according to results from the CLEAR Harmony trial published in The New England Journal of Medicine. Read more.
Out-of-hospital cardiac arrest ranks third in disability burdens
Incidents of out-of-hospital cardiac arrest in adults are the third-highest rate of health loss due to fatal and nonfatal disease burden, according to findings published in Circulation: Cardiovascular Quality and Outcomes. Read more.